Details for New Drug Application (NDA): 085732
✉ Email this page to a colleague
NDA 085732 describes PROPOXYPHENE HYDROCHLORIDE W/ ASPIRIN AND CAFFEINE, which is a drug marketed by Watson Labs and is included in one NDA. Additional details are available on the PROPOXYPHENE HYDROCHLORIDE W/ ASPIRIN AND CAFFEINE profile page.
The generic ingredient in PROPOXYPHENE HYDROCHLORIDE W/ ASPIRIN AND CAFFEINE is aspirin; caffeine; propoxyphene hydrochloride. There are twenty-two drug master file entries for this compound. Additional details are available on the aspirin; caffeine; propoxyphene hydrochloride profile page.
The generic ingredient in PROPOXYPHENE HYDROCHLORIDE W/ ASPIRIN AND CAFFEINE is aspirin; caffeine; propoxyphene hydrochloride. There are twenty-two drug master file entries for this compound. Additional details are available on the aspirin; caffeine; propoxyphene hydrochloride profile page.
Summary for 085732
| Tradename: | PROPOXYPHENE HYDROCHLORIDE W/ ASPIRIN AND CAFFEINE |
| Applicant: | Watson Labs |
| Ingredient: | aspirin; caffeine; propoxyphene hydrochloride |
| Patents: | 0 |
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 389MG;32.4MG;65MG | ||||
| Approval Date: | Sep 3, 1984 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
